Australien - engelska - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - oxygen, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - ? hypoxia of any cause. ? as diluent for gaseous and volatile anaesthetic agents.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - finasteride, quantity: 5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; pregelatinised maize starch; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; docusate sodium; titanium dioxide; hypromellose; indigo carmine aluminium lake; macrogol 400 - treatment of patients with symptomatic benign prostatic hyperplasia (bph) with an enlarged prostate.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine juno is indicated for the treatment of patients with intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), chronic myelomonocytic leukemia (cmmol (10-29 percent marrow blasts without myeloproliferative disorder)), acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azadine is indicated for the treatment of patients with intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), chronic myelomonocytic leukemia (cmmol (10-29 percent marrow blasts without myeloproliferative disorder)), acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), in whom allogenic stem cell transplantation is not indicated.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: crospovidone; maize starch; lactose monohydrate; microcrystalline cellulose; purified talc; macrogol 6000; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; sunset yellow fcf aluminium lake; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; titanium dioxide; purified talc; maize starch; microcrystalline cellulose; quinoline yellow aluminium lake; hypromellose; macrogol 6000; colloidal anhydrous silica - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: magnesium stearate; titanium dioxide; crospovidone; lactose monohydrate; microcrystalline cellulose; hypromellose; macrogol 6000; colloidal anhydrous silica; maize starch; purified talc; brilliant blue fcf aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; macrogol 6000; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; crospovidone; titanium dioxide; maize starch; purified talc; sunset yellow fcf aluminium lake; hypromellose; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: microcrystalline cellulose; purified talc; titanium dioxide; magnesium stearate; sunset yellow fcf aluminium lake; macrogol 6000; crospovidone; lactose monohydrate; hypromellose; maize starch; colloidal anhydrous silica; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: maize starch; crospovidone; microcrystalline cellulose; purified talc; lactose monohydrate; macrogol 6000; titanium dioxide; magnesium stearate; sunset yellow fcf aluminium lake; hypromellose; colloidal anhydrous silica; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.